Director/PDMR Shareholding

Summary by AI BETAClose X

Renalytix plc announced that Joel Jung, interim Chief Financial Officer, purchased 500 American Depositary Shares (ADS) at $2.85 per ADS on February 11, 2026. This transaction increases his total interest to 333,855 Ordinary Shares, representing 0.07% of the company's issued share capital. The purchase of these ADSs, each comprising 50 Ordinary Shares, was conducted on the OTC New York market.

Disclaimer*

UK 100

Latest directors dealings